Jeff Yass’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.46M Buy
329,178
+114,959
+54% +$516K ﹤0.01% 7047
2026
Q2
$853K Buy
214,219
+197,170
+1,156% +$542K ﹤0.01% 8605
2026
Q1
$22.8K Sell
17,049
-19,317
-53% -$38.5K ﹤0.01% 12834
2025
Q4
$89.1K Buy
+36,366
New +$158K ﹤0.01% 11515
2025
Q3
– Sell
-58,246
Closed -$342K – 13890
2025
Q2
$342K Sell
58,246
-5,728
-9% -$37.3K ﹤0.01% 10045
2025
Q1
$537K Sell
63,974
-9,986
-14% -$89.7K ﹤0.01% 8748
2024
Q4
$550K Buy
73,960
+12,757
+21% +$85.4K ﹤0.01% 8433
2024
Q3
$355K Sell
61,203
-56,470
-48% -$363K ﹤0.01% 9240
2024
Q2
$783K Buy
117,673
+97,895
+495% +$791K ﹤0.01% 7167
2024
Q1
$258K Buy
19,778
+4,236
+27% +$56.5K ﹤0.01% 10048
2023
Q4
$198K Buy
+15,542
New +$157K ﹤0.01% 10694
2023
Q3
– Sell
-24,351
Closed -$446K – 12983
2023
Q2
$623K Sell
24,351
-20,495
-46% -$529K ﹤0.01% 7794
2023
Q1
$1.13M Buy
44,846
+32,695
+269% +$768K ﹤0.01% 6494
2022
Q4
$279K Sell
12,151
-1,423
-10% -$32.8K ﹤0.01% 9266
2022
Q3
$300K Sell
13,574
-4,136
-23% -$80K ﹤0.01% 9790
2022
Q2
$254K Buy
+17,710
New +$298K ﹤0.01% 10013

Other funds holding TMCI

Jeff Yass's TMCI Position: Q3 2026 in Review

Jeff Yass increased its Treace Medical Concepts (TMCI) stake by 54% in Q3 2026, buying an estimated $516K and bringing the position to 329,178 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #7047.

Jeff Yass first reported a position in TMCI in Q2 2022 and has held it in 16 quarters since. 116 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Jeff Yass held 329,178 shares of Treace Medical Concepts worth $1.46M as of Q3 2026.
  • Jeff Yass bought 114,959 Treace Medical Concepts shares in Q3 2026, an estimated $516K.
  • Treace Medical Concepts made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7047 holding.
  • Jeff Yass first reported a position in Treace Medical Concepts in Q2 2022 and has held it in 16 quarters since.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.